<p>Alignment Healthcare, Inc.（納斯達克代碼：ALHC - 獲取免費報告）的股票在週四下跌了 4.3%，原因是公司內部人士出售了股票。該股最低交易價為 14.33 美元，最後交易價為 14.67 美元。在午盤交易中，共交易了 1,046,953 股，較平均交易量 1,912,671 股下降了 45%。該股此前收盤價為 15.33 美元。</p>
<p>獲取 <strong>Alignment Healthcare</strong> 的提醒：</p>
<p>具體來説，董事 Atlantic（Aln Hlth）L. General 在 5 月 19 日（星期一）出售了 17,000,000 股公司的股票，交易價格為每股 15.28 美元，總價值為 259,760,000.00 美元。交易完成後，該董事現在持有 44,302,175 股公司的股票，價值 676,937,234 美元。這筆交易代表了他們持股比例的 27.73% 的減少。該出售在向 SEC 的文件中披露，文件可通過此鏈接查看。</p>
<h2>分析師設定新目標價</h2>
<p>幾位股票研究分析師最近對該公司發佈了報告。Stephens 在 2 月 24 日（星期一）的研究報告中重申了 “增持” 評級，並對 Alignment Healthcare 的股票設定了 17.00 美元的目標價。Piper Sandler 在 3 月 4 日（星期二）的報告中將 Alignment Healthcare 的目標價從 14.00 美元上調至 21.00 美元，並給予該股 “增持” 評級。摩根大通將 Alignment Healthcare 的目標價從 14.00 美元上調至 17.00 美元，並在 3 月 6 日（星期四）的研究報告中給予該公司 “中性” 評級。Stifel Nicolaus 在 4 月 8 日（星期二）的研究報告中將 Alignment Healthcare 的目標價從 18.00 美元上調至 23.00 美元，並給予該公司 “買入” 評級。最後，巴克萊在 2 月 28 日（星期五）的研究報告中將 Alignment Healthcare 的目標價從 8.00 美元上調至 9.00 美元，並給予該公司 “減持” 評級。一位股票研究分析師對該股給予了賣出評級，三位給予了持有評級，七位給予了買入評級，一位給予了強烈買入評級。根據 MarketBeat.com 的數據，該公司的平均評級為 “適度買入”，平均目標價為 17.17 美元。</p>
<p><strong>查看我們對 Alignment Healthcare 的最新股票分析</strong></p>
<h2>Alignment Healthcare 的價格表現</h2>
<p>該公司的 50 日簡單移動平均線為 17.31 美元，200 日簡單移動平均線為 14.63 美元。該公司的速動比率為 1.60，流動比率為 1.60，債務與股本比率為 1.82。該股的市值為 29.1 億美元，市盈率為-19.09，貝塔值為 1.32。</p>
<p>Alignment Healthcare（納斯達克代碼：ALHC - 獲取免費報告）最近於 5 月 1 日（星期四）發佈了季度財報。該公司報告的每股收益（EPS）為-0.05 美元，超過了市場共識預期的-0.12 美元，超出幅度為 0.07 美元。Alignment Healthcare 的股本回報率為-108.69%，淨利潤率為-5.84%。該公司在本季度的收入為 9.2693 億美元，而市場共識預期為 8.8983 億美元。在去年同期，該公司的每股收益為-0.25 美元。該公司的收入同比增長了 47.5%。股票研究分析師預測，Alignment Healthcare, Inc.在當前年度的每股收益將為-0.69 美元。</p>
<h2>Alignment Healthcare 的機構交易</h2>
<p>一些機構投資者和對沖基金最近調整了對 ALHC 的持股。Wellington Management Group LLP 在第四季度將其在 Alignment Healthcare 的持股增加了 77.9%。Wellington Management Group LLP 目前持有 7,438,500 股該公司的股票，價值 83,683,000 美元，此前在上個季度增持了 3,257,630 股。T. Rowe Price Investment Management Inc.在第四季度將其在 Alignment Healthcare 的持股增加了 54.7%。T. Rowe Price Investment Management Inc.目前持有 8,649,042 股該公司的股票，價值 97,302,000 美元，此前在上個季度增持了 3,059,596 股。Millennium Management LLC 在第四季度將其在 Alignment Healthcare 的持股增加了 588.3%。Millennium Management LLC 目前持有 3,388,602 股該公司的股票，價值 38,122,000 美元，此前在該期間增持了 2,896,311 股。Point72 Asset Management L.P.在第四季度獲得了 Alignment Healthcare 的新股份，價值約為 20,087,000 美元。最後，Invesco Ltd.在第一季度將其在 Alignment Healthcare 的持股增加了 1,415.7%。Invesco Ltd.目前持有 1,875,790 股該公司的股票，價值 34,927,000 美元，此前在上個季度增持了 1,752,033 股。目前 86.19% 的股票由機構投資者和對沖基金持有。</p>
<h2>關於 Alignment Healthcare</h2>
<p>（獲取免費報告）</p>
<p>Alignment Healthcare, Inc.是一家技術驅動的醫療保險優勢公司，為美國的老年人運營以消費者為中心的醫療保健平台。它通過其醫療保險優勢計劃提供定製的醫療保健，以滿足各種老年人的需求。該公司成立於 2013 年，總部位於加利福尼亞州橙縣。</p>
<h2>閲讀更多</h2>
<ul>
<li>我們更喜歡的五隻股票超過 Alignment Healthcare</li>
<li>紐約證券交易所股票為投資者提供多種優質選擇</li>
<li>這四位頂級投資者在第一季度購買了超過 600 萬股博通股票</li>
<li>三隻股票保護您的投資組合免受冠狀病毒傳播的影響</li>
<li>買入低位？三隻油股有望大幅反彈</li>
<li>恒生指數是什麼？</li>
<li>Archer 反駁空頭，指出強勁的第一季度及全球勢頭</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前經過 MarketBeat 編輯團隊的審核。如對該故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 Alignment Healthcare 嗎？</h2>
<p>在考慮 Alignment Healthcare 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻股票，頂級分析師正在悄悄地向他們的客户推薦在更廣泛的市場注意到之前購買……而 Alignment Healthcare 並不在名單上。</p>
<p>雖然 Alignment Healthcare 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

ALHC

<p>Alignment Healthcare（納斯達克代碼：ALHC）的股價下跌了 4.3%，原因是內部人士以每股 15.28 美元出售了 1700 萬股，減少了 27.73% 的持股比例。該股票的交易區間為 14.33 美元至 14.67 美元，成交量下降了 45%。分析師的評級不一，價格目標範圍從 9.00 美元到 23.00 美元不等。公司報告的年同比收入增長為 47.5%，季度每股收益為-0.05 美元，超出預期。機構投資者持有 86.19% 的股份，顯示出強烈的機構興趣</p>

<p>Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) traded down 4.3% on Thursday after an insider sold shares in the company. The stock traded as low as $14.33 and last traded at $14.67. 1,046,953 shares were traded during mid-day trading, a decline of 45% from the average session volume of 1,912,671 shares. The stock had previously closed at $15.33.</p>
<div class="lb-trans"><p>Alignment Healthcare, Inc.（納斯達克代碼：ALHC - 獲取免費報告）的股票在週四下跌了 4.3%，原因是公司內部人士出售了股票。該股最低交易價為 14.33 美元，最後交易價為 14.67 美元。在午盤交易中，共交易了 1,046,953 股，較平均交易量 1,912,671 股下降了 45%。該股此前收盤價為 15.33 美元。</p>
</div><p>Get <strong>Alignment Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Alignment Healthcare</strong> 的提醒：</p>
</div><p>Specifically, Director Atlantic (Aln Hlth) L. General sold 17,000,000 shares of the firm's stock in a transaction on Monday, May 19th. The stock was sold at an average price of $15.28, for a total value of $259,760,000.00. Following the completion of the sale, the director now owns 44,302,175 shares of the company's stock, valued at $676,937,234. This trade represents a 27.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link.</p>
<div class="lb-trans"><p>具體來説，董事 Atlantic（Aln Hlth）L. General 在 5 月 19 日（星期一）出售了 17,000,000 股公司的股票，交易價格為每股 15.28 美元，總價值為 259,760,000.00 美元。交易完成後，該董事現在持有 44,302,175 股公司的股票，價值 676,937,234 美元。這筆交易代表了他們持股比例的 27.73% 的減少。該出售在向 SEC 的文件中披露，文件可通過此鏈接查看。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>Several equities research analysts recently issued reports on the company. Stephens reissued an &#34;overweight&#34; rating and issued a $17.00 price objective on shares of Alignment Healthcare in a research note on Monday, February 24th. Piper Sandler raised their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an &#34;overweight&#34; rating in a report on Tuesday, March 4th. JPMorgan Chase &amp; Co. boosted their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the company a &#34;neutral&#34; rating in a research report on Thursday, March 6th. Stifel Nicolaus upped their price objective on shares of Alignment Healthcare from $18.00 to $23.00 and gave the company a &#34;buy&#34; rating in a research note on Tuesday, April 8th. Finally, Barclays lifted their target price on shares of Alignment Healthcare from $8.00 to $9.00 and gave the company an &#34;underweight&#34; rating in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of &#34;Moderate Buy&#34; and an average price target of $17.17.</p>
<div class="lb-trans"><p>幾位股票研究分析師最近對該公司發佈了報告。Stephens 在 2 月 24 日（星期一）的研究報告中重申了 “增持” 評級，並對 Alignment Healthcare 的股票設定了 17.00 美元的目標價。Piper Sandler 在 3 月 4 日（星期二）的報告中將 Alignment Healthcare 的目標價從 14.00 美元上調至 21.00 美元，並給予該股 “增持” 評級。摩根大通將 Alignment Healthcare 的目標價從 14.00 美元上調至 17.00 美元，並在 3 月 6 日（星期四）的研究報告中給予該公司 “中性” 評級。Stifel Nicolaus 在 4 月 8 日（星期二）的研究報告中將 Alignment Healthcare 的目標價從 18.00 美元上調至 23.00 美元，並給予該公司 “買入” 評級。最後，巴克萊在 2 月 28 日（星期五）的研究報告中將 Alignment Healthcare 的目標價從 8.00 美元上調至 9.00 美元，並給予該公司 “減持” 評級。一位股票研究分析師對該股給予了賣出評級，三位給予了持有評級，七位給予了買入評級，一位給予了強烈買入評級。根據 MarketBeat.com 的數據，該公司的平均評級為 “適度買入”，平均目標價為 17.17 美元。</p>
</div><p><strong>Check Out Our Latest Stock Analysis on Alignment Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我們對 Alignment Healthcare 的最新股票分析</strong></p>
</div><h2>Alignment Healthcare Price Performance</h2>
<div class="lb-trans"><h2>Alignment Healthcare 的價格表現</h2>
</div><p>The company's 50-day simple moving average is $17.31 and its 200 day simple moving average is $14.63. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The stock has a market capitalization of $2.91 billion, a price-to-earnings ratio of -19.09 and a beta of 1.32.</p>
<div class="lb-trans"><p>該公司的 50 日簡單移動平均線為 17.31 美元，200 日簡單移動平均線為 14.63 美元。該公司的速動比率為 1.60，流動比率為 1.60，債務與股本比率為 1.82。該股的市值為 29.1 億美元，市盈率為-19.09，貝塔值為 1.32。</p>
</div><p>Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.07. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The company had revenue of $926.93 million during the quarter, compared to the consensus estimate of $889.83 million. During the same quarter in the prior year, the company posted ($0.25) EPS. The firm's revenue was up 47.5% on a year-over-year basis. Equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.</p>
<div class="lb-trans"><p>Alignment Healthcare（納斯達克代碼：ALHC - 獲取免費報告）最近於 5 月 1 日（星期四）發佈了季度財報。該公司報告的每股收益（EPS）為-0.05 美元，超過了市場共識預期的-0.12 美元，超出幅度為 0.07 美元。Alignment Healthcare 的股本回報率為-108.69%，淨利潤率為-5.84%。該公司在本季度的收入為 9.2693 億美元，而市場共識預期為 8.8983 億美元。在去年同期，該公司的每股收益為-0.25 美元。該公司的收入同比增長了 47.5%。股票研究分析師預測，Alignment Healthcare, Inc.在當前年度的每股收益將為-0.69 美元。</p>
</div><h2>Institutional Trading of Alignment Healthcare</h2>
<div class="lb-trans"><h2>Alignment Healthcare 的機構交易</h2>
</div><p>A number of institutional investors and hedge funds have recently modified their holdings of ALHC. Wellington Management Group LLP lifted its position in Alignment Healthcare by 77.9% during the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company's stock worth $83,683,000 after acquiring an additional 3,257,630 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its position in shares of Alignment Healthcare by 54.7% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company's stock worth $97,302,000 after purchasing an additional 3,059,596 shares during the last quarter. Millennium Management LLC boosted its stake in Alignment Healthcare by 588.3% during the 4th quarter. Millennium Management LLC now owns 3,388,602 shares of the company's stock valued at $38,122,000 after purchasing an additional 2,896,311 shares during the period. Point72 Asset Management L.P. acquired a new stake in Alignment Healthcare in the 4th quarter valued at approximately $20,087,000. Finally, Invesco Ltd. grew its holdings in Alignment Healthcare by 1,415.7% in the 1st quarter. Invesco Ltd. now owns 1,875,790 shares of the company's stock valued at $34,927,000 after buying an additional 1,752,033 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些機構投資者和對沖基金最近調整了對 ALHC 的持股。Wellington Management Group LLP 在第四季度將其在 Alignment Healthcare 的持股增加了 77.9%。Wellington Management Group LLP 目前持有 7,438,500 股該公司的股票，價值 83,683,000 美元，此前在上個季度增持了 3,257,630 股。T. Rowe Price Investment Management Inc.在第四季度將其在 Alignment Healthcare 的持股增加了 54.7%。T. Rowe Price Investment Management Inc.目前持有 8,649,042 股該公司的股票，價值 97,302,000 美元，此前在上個季度增持了 3,059,596 股。Millennium Management LLC 在第四季度將其在 Alignment Healthcare 的持股增加了 588.3%。Millennium Management LLC 目前持有 3,388,602 股該公司的股票，價值 38,122,000 美元，此前在該期間增持了 2,896,311 股。Point72 Asset Management L.P.在第四季度獲得了 Alignment Healthcare 的新股份，價值約為 20,087,000 美元。最後，Invesco Ltd.在第一季度將其在 Alignment Healthcare 的持股增加了 1,415.7%。Invesco Ltd.目前持有 1,875,790 股該公司的股票，價值 34,927,000 美元，此前在上個季度增持了 1,752,033 股。目前 86.19% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>About Alignment Healthcare</h2>
<div class="lb-trans"><h2>關於 Alignment Healthcare</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.</p>
<div class="lb-trans"><p>Alignment Healthcare, Inc.是一家技術驅動的醫療保險優勢公司，為美國的老年人運營以消費者為中心的醫療保健平台。它通過其醫療保險優勢計劃提供定製的醫療保健，以滿足各種老年人的需求。該公司成立於 2013 年，總部位於加利福尼亞州橙縣。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>閲讀更多</h2>
</div><ul>
<li>Five stocks we like better than Alignment Healthcare</li>
<li>NYSE Stocks Give Investors a Variety of Quality Options</li>
<li>These 4 Top Investors Bought Over 6 Million Broadcom Shares in Q1</li>
<li>3 Stocks to Protect Your Portfolio from the Coronavirus Contagion</li>
<li>Buy the Dip? 3 Oil Stocks Poised for a Big Comeback</li>
<li>What is the Hang Seng index?</li>
<li>Archer Rebuts Short Seller, Points to Strong Q1 &amp; Global Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更喜歡的五隻股票超過 Alignment Healthcare</li>
<li>紐約證券交易所股票為投資者提供多種優質選擇</li>
<li>這四位頂級投資者在第一季度購買了超過 600 萬股博通股票</li>
<li>三隻股票保護您的投資組合免受冠狀病毒傳播的影響</li>
<li>買入低位？三隻油股有望大幅反彈</li>
<li>恒生指數是什麼？</li>
<li>Archer 反駁空頭，指出強勁的第一季度及全球勢頭</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前經過 MarketBeat 編輯團隊的審核。如對該故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Alignment Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Alignment Healthcare 嗎？</h2>
</div><p>Before you consider Alignment Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Alignment Healthcare 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻股票，頂級分析師正在悄悄地向他們的客户推薦在更廣泛的市場注意到之前購買……而 Alignment Healthcare 並不在名單上。</p>
</div><p>While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Alignment Healthcare 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Alignment Healthcare (NASDAQ:ALHC) Trading Down 4.3% on Insider Selling

Alignment Healthcare（納斯達克股票代碼：ALHC）因內部人士出售股票而下跌 4.3%